Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Ampliphi Biosciences Corp (APHB)

1.22 0.021 (1.75%)

05-24 16:00

Open:

1.21

Pre. Close:

1.199

High:

1.24

Low:

1.15

Volume:

64,760

Market Cap:

20M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.231 - 1.237

1.237 - 1.243

Low:

1.136 - 1.142

1.142 - 1.148

Close:

1.22 - 1.23

1.23 - 1.24

Technical analysis  (as of: 2018-05-24 5:25:09 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 1.46     One year: 1.71

Support:

Support1: 1.13    Support2: 1.05

Resistance:

Resistance1: 1.25    Resistance2: 1.46

Pivot:

1.14

Moving Averages:

MA(5): 1.21     MA(20): 1.13

MA(100): 1.22     MA(250): 1.06

MACD:

MACD(12,26): 0.01     Signal(12,26,9):

%K %D:

%K(14,3): 79.83     %D(3): 81.62

RSI:

RSI(14): 57.87

52-Week:

High: 2.05  Low: 0.67  Change(%): 65.1

Average Vol(K):

3-Month: 28817  10-Days 18282

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
APHB has closed below upper band by 11.3%. Bollinger Bands are 42.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to APHB's normal range. The bands have been in this narrow range for 32 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-20T21:19:32-04:00
Reader Inquiry: Is A Run-Up In The Cards For AmpliPhi BioSciences?

2018-05-18T06:50:00-04:00
AmpliPhi Biosciences to Present at 5th World Congress on Targeting Infectious Diseases: Targeting Phage & Antibiotic Resistance 2018

2018-05-16T14:19:48-04:00
Ampliphi Biosciences Corp. 2018 Q1 - Results - Earnings Call Slides

2018-05-15T20:38:08-04:00
AmpliPhi Biosciences' (APHB) CEO Paul Grint on Q1 2018 Results - Earnings Call Transcript

2018-05-15T16:08:58-04:00
AmpliPhi Biosciences misses by $0.05

2018-05-15T16:02:00-04:00
AmpliPhi Biosciences Reports First Quarter 2018 Financial Results and Business Highlights

2018-05-08T06:50:00-04:00
AmpliPhi Biosciences to Hold 2018 First Quarter and Business Update Conference Call on May 15

2018-05-03T16:15:00-04:00
AmpliPhi Biosciences Will Utilize NIAID Preclinical Services to Advance Development of Its Targeted Therapeutic Candidate for the Treatment of Resistant Staphylococcus Aureus

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

16.46

Shares Float (M)

16.02

% Held by Insiders

3.30

% Held by Institutions

19.70

Shares Short (K)

930

Shares Short Prior Month (K)

1310

Stock Financials

EPS

-3.060

EPS Est. Current Year

-2.870

EPS Est. Next Year

-1.330

EPS Est. Next Quarter

-3.800

Forward EPS

-0.841

Book Value (p.s.)

2.280

PEG Ratio

Profit Margin

Operating Margin

-9005.22

Return on Assets (ttm)

-87.7

Return on Equity (ttm)

-147.1

Qtrly Rev. Growth

-9.1

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.821

Qtrly Earnings Growth

Operating Cash Flow (M)

-9.19

Levered Free Cash Flow (M)

-5.87

atoplab.com

Valuation

P/E

-0.40

P/E Growth Ratio

0.03

P/BV

0.54

P/S

1012290048.00

P/CF

-2.20

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-04-25

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.